Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GERD - PPI Responders”

11 trials

Showing 11 of 11 results

Early research (Phase 1)Study completedNCT01095133
What this trial is testing

Do Acid Sensing Ion Channels Contribute to Heartburn?

Who this might be right for
Gastroesophageal Reflux DiseaseHeartburn
University of North Carolina, Chapel Hill 24
Very early researchStudy completedNCT03202537
What this trial is testing

Effectiveness of Physiologic Testing in PPI Non-Responders

Who this might be right for
Gastro Esophageal Reflux
Northwestern University 240
Testing effectiveness (Phase 2)Study completedNCT00810485
What this trial is testing

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Who this might be right for
Gastroesophageal Reflux
Addex Pharma S.A. 298
Large-scale testing (Phase 3)Looking for participantsNCT07063576
What this trial is testing

Effect of Baclofen in Management of Patients With Gastroesophageal Reflux Disease Symptoms

Who this might be right for
GERD - PPI Non-responders
Adnan Imtiaj Rahul 60
Not applicableStudy completedNCT00795093
What this trial is testing

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
AstraZeneca 552
Testing effectiveness (Phase 2)Study completedNCT00978016
What this trial is testing

Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux Disease
XenoPort, Inc. 460
Testing effectiveness (Phase 2)Looking for participantsNCT05556824
What this trial is testing

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

Who this might be right for
Gastroesophageal Reflux
Microbiome Health Sciences 247
Not applicableStudy completedNCT02199002
What this trial is testing

Acid Pocket: Position and Aspiration

Who this might be right for
GERD - PPI RespondersGERD - PPI Non-respondersBarrett Esophagus+1 more
KU Leuven 70
Not applicableWithdrawnNCT03282084
What this trial is testing

A Prospective, Observational Study of the PPI Non-responder

Who this might be right for
Gastro Esophageal Reflux Disease PPI Non-Responders
Dartmouth-Hitchcock Medical Center
Not applicableStudy completedNCT00842855
What this trial is testing

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

Who this might be right for
Gastroesophageal Reflux Disease
AstraZeneca 275
Testing effectiveness (Phase 2)Ended earlyNCT00730665
What this trial is testing

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux Disease
Pfizer 81

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation